BioMarin to Present at 37th Annual J.P. Morgan Healthcare Conference in San Francisco

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 8:30 am PT, or 11:30 am ET, in San Francisco, California.

SAN RAFAEL, Calif. /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 8:30 am PT, or 11:30 am ET, in San Francisco, California. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following the event.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company’s portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.biomarin.com. Information on BioMarin’s website is not incorporated by reference into this press release.

Contacts:

Investors

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-present-at-37th-annual-jp-morgan-healthcare-conference-in-san-francisco-300765561.html

SOURCE BioMarin Pharmaceutical Inc.


Company Codes: NASDAQ-NMS:BMRN
MORE ON THIS TOPIC